You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study

Article metrics

Article menu

This article has a correction. Please see:

Clinical/translational cancer immunotherapy
Original research
Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2026

AbstractFullPdf
Nov 2022515112
Dec 2022566578263
Jan 202328128692
Feb 202320421193
Mar 202319719797
Apr 202310710858
May 2023899041
Jun 2023767632
Jul 2023687035
Aug 2023697037
Sep 2023798045
Oct 2023929462
Nov 2023707050
Dec 2023838944
Jan 202410410667
Feb 2024898956
Mar 202412212261
Apr 20249710042
May 2024798047
Jun 2024929363
Jul 2024828351
Aug 2024737441
Sep 2024858544
Oct 2024969759
Nov 20249710260
Dec 202413413570
Jan 2025848556
Feb 202520921055
Mar 202510510564
Apr 202510911057
May 2025808357
Jun 2025828754
Jul 2025110
Mar 2026110
Total385339181965